Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Dec 2;172(2):175–179. doi: 10.1007/s10517-021-05358-2

Simultaneous Administration of NOD-2 (MDP) and TLP-4 (LPS) Ligands to Bone Marrow Donors 24 h before Transplantation Increases the Content of Multipotent Stromal Cells (MSCs) in Bone Marrow Grafts in CBA Mice Compared to the Total Result of Their Isolated Administration

Yu F Gorskaya 1,✉, E N Semenova 1, E V Nagurskaya 1, V A Bekhalo 1, V G Nesterenko 1
PMCID: PMC8635759  PMID: 34853967

Abstract

In 3-month bone marrow transplants of CBA mice from bone marrow donors receiving single injections of TLR-4 ligand (LPS) or NOD-2 ligand (muramyl dipeptide, MDP) 24 h before transplantation, an increase in the total number of MSCs (by 2.6 and 1.9 times, respectively), as well as a slight increase in the number of nuclear cells and the mass of bone capsules (by 1.3 and 1.2 times) were observed. After combined administration of MDР and LPS to donors, the total content of MSCs in the grafts was higher by 1.6 times in comparison with the total result of their isolated administration (and by 7.2 times in comparison with the control). At the same time, the concentration of osteogenic MSCs in the grafts of all groups was almost the same and corresponded to the control level. The number of nuclear cells and the mass of bone capsules of the grafts after combined administration of LPS and MDP were close (~80%) to the sum of the results of their isolated administration. These findings suggest that activation of the stromal tissue and the success of bone marrow transplantation depend on the intensity of innate immune responses. These data can be useful for the development of optimal methods of tissue transplantation.

Key Words: transplantation, MSCs, immune response, NLR and TLR ligands

Footnotes

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 172, No. 8, pp. 205-211, August, 2021

References

  • 1.Gorskaya YF, Danilova TA, Grabko VI, Nesterenko VG. Successive Administration of Streptococcus Type 5 Group A Antigens and S. typhimurium Antigenic Complex Corrects Elevation of Serum Cytokine Concentration and Number of Bone Marrow Stromal Pluripotent Cells in CBA Mice Induced by Each Antigen Separately. Bull. Exp. Biol. Med. 2015;160(2):256–259. doi: 10.1007/s10517-015-3143-y. [DOI] [PubMed] [Google Scholar]
  • 2.Gorskaya YF, Danilova TA, Karyagina AS, Lunin VG, Grabko VI, Bartov MS, Gromov AV, Grunina TM, Soboleva LA, Shapoval IM, Nesterenko VG. Effects of combined treatment with complex S. typhimurium antigens and factors stimulating osteogenesis (curettage, BMP-2) on multipotent bone marrow stromal cells and serum concentration of cytokines in CBA mice. Bull. Exp. Biol. Med. 2015;158(4):465–470. doi: 10.1007/s10517-015-2786-z. [DOI] [PubMed] [Google Scholar]
  • 3.Gorskaya UF, Danilova TA, Mezentzeva MV, Shapoval MM, Nesterenko VG. Effect of immunization with polyvinylpyrrolidone on the counts of stromal precursor cells in bone marrow and spleen of CBA and CBA/N mice and cytokine gene expression in primary cultures of these cells. Bull. Exp. Biol. Med. 2012;153(1):64–67. doi: 10.1007/s10517-012-1644-5. [DOI] [PubMed] [Google Scholar]
  • 4.Gorskaya UF, Danilova TA, Nesterenko VG. Counts of stromal precursor cells in the bone marrow and heterotopic bone marrow transplants from mice immunized with group A streptococcus antigens during different periods after immunization. Bull. Exp. Biol. Med. 2009;147(1):73–76. doi: 10.1007/s10517-009-0443-0. [DOI] [PubMed] [Google Scholar]
  • 5.Gorskaya YF, Nesterenko VG. The Content of Multipotent Stromal Cells in 3-4.5-Month Heterotopic Bone Marrow Transplants of CBA Mice Subjected to a Single Exposure to Osteogenic Stimuli (Curettage, BMP-2) or Antigens (S. typhimurium antigenic complex, LPS) Bull. Exp. Biol. Med. 2017;163(1):137–141. doi: 10.1007/s10517-017-3754-6. [DOI] [PubMed] [Google Scholar]
  • 6.Gorskaya YF, Tukhvatulin AI, Dzharullaeva AS, Nesterenko VG. Ligands of NOD2 (Muramyl Dipeptide) and TLR4 (LPS) in 24 h after Combined In Vivo Administration Produce a Synergistic Increase in the Content of Multipotent Stromal Cells in the Bone Marrow and Peritoneal Exudate of CBA Mice. Bull. Exp. Biol. Med. 2019;166(4):473–476. doi: 10.1007/s10517-019-04375-6. [DOI] [PubMed] [Google Scholar]
  • 7.Gorskaya YF, Tukhvatulin AI, Dzharullaeva AS, Nesterenko VG. Combined Administration of TLR4 (LPS) and TLR3 (Poly I:C) Ligands to CBA Mice Elevates the Content of Osteogenic MSC by 1.6 Times and Increases Content of Bone Marrow MSC to Intermediate Level between Values Attained by Their Individual Administration. Bull. Exp. Biol. Med. 2020;168(6):767–772. doi: 10.1007/s10517-020-04798-6. [DOI] [PubMed] [Google Scholar]
  • 8.Gorskaya YF, Tukhvatulin AI, Nesterenko VG. NLR2 and TLR3, TLR4, TLR5 Ligands, Injected In Vivo, Improve after 1 h the Efficiency of Cloning and Proliferative Activity of Bone Marrow Multipotent Stromal Cells and Reduce the Content of Osteogenic Multipotent Stromal Cells in CBA Mice. Bull. Exp. Biol. Med. 2017;163(3):356–360. doi: 10.1007/s10517-017-3803-1. [DOI] [PubMed] [Google Scholar]
  • 9.Kostarnoy AV, Logunov DY, Verkhovskaya LV, Gancheva PG, Naroditsky BS. Influence of S. typhi lipopolisaccharide upon epithelization of skin wounds and epidermal growth factor secretion. Med. Immunol. 2012;14(3):223–226. doi: 10.15789/1563-0625-2012-3-223-226. [DOI] [Google Scholar]
  • 10.Gorskaya YF, Semenova EN, Nagurskaya EV, Bekhalo VA, Nesterenko VG. Apoptosis and P53 activation are involved in COVID-19 pathogenesis. COVID-19 Pandemic: Case Studies & Opinions. 2021;2(2):208–213. [Google Scholar]
  • 11.Kuznetsov SA, Mankani MH, Robey PG. In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. J. Tissue Eng. Regen. Med. 2013;7(3):226–235. doi: 10.1002/term.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Major J, Crotta S, Llorian M, McCabe TM, Gad HH, Priestnall SL, Hartmann R, Wack A. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science. 2020;369:712–717. doi: 10.1126/science.abc2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Najar M, Krayem M, Meuleman N, Bron D, Lagneaux L. Mesenchymal stromal cells and Toll-Like Receptor priming: a critical review. Immune Netw. 2017;17(2):89–102. doi: 10.4110/in.2017.17.2.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tukhvatulin AI, Gitlin II, Shcheblyakov DV, Artemicheva NM, Burdelya LG, Shmarov MM, Naroditsky BS, Gudkov AV, Gintsburg AL, Logunov DY. Combined stimulation of Toll-like receptor 5 and NOD1 strongly potentiates activity of NF-κB, resulting in enhanced innate immune reactions and resistance to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2013;81(10):3855–3864. doi: 10.1128/IAI.00525-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.van Heel DA, Ghosh S, Butler M, Hunt K, Foxwell BM, Mengin-Lecreulx D, Playford RJ. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur. J. Immunol. 2005;35(8):2471–2476. doi: 10.1002/eji.200526296. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of Experimental Biology and Medicine are provided here courtesy of Nature Publishing Group

RESOURCES